Asthma Severity in Children and Environmental Agents
Completed
- Conditions
- Asthma
- Registration Number
- NCT00042705
- Lead Sponsor
- National Institute of Environmental Health Sciences (NIEHS)
- Brief Summary
This study measures residential exposures (indoor allergens, mold, nitrogen dioxide, nicotine) and relates exposure levels to daily symptoms (wheeze, persistent cough, chest tightness, shortness of breath) and medication use, in a population of children with physician diagnosed asthma, followed for 12 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link indoor allergens to asthma symptom exacerbation in children as studied in NCT00042705?
How do findings from NCT00042705 compare with standard-of-care treatments for pediatric asthma exacerbation management?
What biomarkers correlate with asthma severity in children exposed to mold and nitrogen dioxide according to NCT00042705?
What adverse events are associated with environmental exposure mitigation strategies in pediatric asthma populations?
How do combination approaches of allergen avoidance and pharmacotherapy impact asthma outcomes in children as per NCT00042705?
Trial Locations
- Locations (1)
Yale Center for Perinatal, Pediatric & Environmental Epidemiology
🇺🇸New haven, Connecticut, United States
Yale Center for Perinatal, Pediatric & Environmental Epidemiology🇺🇸New haven, Connecticut, United States